VENOUS THROMBOEMBOLISM

This study tested a special sheath (Protrieve) placed in a large vein to catch blood clots that might break loose during a procedure to treat deep vein thrombosis (DVT). The goal was to prevent those clots from reaching the lungs and causing a pulmonary embolism. The study involv…

This study compared two blood thinners, rivaroxaban and apixaban, to see which causes fewer bleeding problems in people with blood clots in the legs or lungs. About 2,760 adults took part, and researchers tracked serious and minor bleeding events. The goal was to help doctors cho…

This study tested whether a low dose of the blood thinner apixaban (2.5 mg twice daily) can safely prevent blood clots from coming back in people who already had a clot triggered by a temporary risk factor (like surgery or injury) but still have ongoing risks (like obesity or lim…

This study looked at whether the blood thinner Xarelto (rivaroxaban) can safely prevent dangerous blood clots in the legs or lungs after total hip or knee replacement surgery. 150 patients in Taiwan were randomly assigned to receive Xarelto or standard care. The researchers measu…

This study tested an experimental drug called REGN7508 in 179 adults having knee replacement surgery. The goal was to see if it could prevent dangerous blood clots (venous thromboembolism) better than standard care. Researchers also monitored side effects and how the drug behaves…

This study tested two experimental drugs (REGN9933 and REGN7508) to see if they can prevent blood clots in adults who need a PICC line—a tube placed in a vein for medical treatment. About 195 participants received either the drug or a placebo. The goal was to check how well the d…

This study tested whether a small, wearable device called Geko, which uses mild electrical pulses to stimulate leg muscles, can help prevent dangerous blood clots in critically ill adults. Forty intensive care patients were randomly assigned to receive either the Geko device or s…

This study looked at whether notifying a pharmacist about a risky blood thinner prescription works better than notifying the doctor. Researchers tested two types of alerts with 306 prescribers and pharmacists. The goal was to see which method led to faster and more frequent presc…

This study talked to children aged 12 to 21 with bleeding or clotting disorders to understand how their condition affects their daily life, emotions, and future plans. Researchers used interviews and questionnaires to learn about quality of life, confidence in managing their diso…

This study looked at 744 people who had a blood clot before to see if doctors can better predict when another clot will happen. Researchers tested three common tools that use symptoms and medical history to decide if more tests are needed. The goal is to avoid missing dangerous c…

This study looked at whether two blood markers—nucleosomes and free DNA—stay consistent over time in healthy people and in patients who have had a blood clot (venous thromboembolism). Researchers took monthly blood samples from 15 healthy volunteers and 15 patients for six months…

This study looked at how often blood clots (venous thromboembolism) occur in people with pelvic or hip-socket fractures who received standard clot-preventing medication. 81 adults were monitored with ultrasound scans during their hospital stay. The goal was to better understand c…

This study looked for certain genetic mutations in blood cells of 150 people over 50 who had a history of venous thromboembolism (blood clots). The goal was to see how common these mutations are in this group. No treatment was given; the study only observed and analyzed DNA sampl…

This study followed 1,000 people who had blood clots in their veins (venous thromboembolism) for several years. Researchers wanted to learn which patients need long-term blood-thinning medication and understand how the disease progresses. Participants had yearly check-ups by phon…

This study looks at medical records of children under 18 in Japan who were prescribed rivaroxaban or warfarin for blood clots. Researchers want to see how often serious bleeding happens with each drug in everyday care. No extra tests or visits are needed—only existing health data…

This study compared two common blood thinners, rivaroxaban and apixaban, to see which causes less bleeding in people with blood clots. It involved 72 adults with new clots in the legs or lungs. The main goal was to test if a larger study is possible, not to declare a winner.